MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced a broad alliance with the Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, covering the use of fully human recombinant research antibodies and commercialization of r
Discuss Add this link to... Bury
Comments